Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium in localized prostate cancer
NCT02198859Phase 1Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Apr 2014
- Primary completion
- Aug 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label trial of lithium carbonate in prostate cancer (PCa), sponsored by University of Kansas Medical Center. Primary endpoints: Adverse Events at 2 weeks and Performance Status at 2 weeks. Started Apr 2014; status: completed.
02
Drugs
lithium carbonate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02198859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198859.